The global intragastric balloons market was valued at $32.2 million in 2023, and is projected to reach $115.3 million by 2033, growing at a CAGR of 13.6% from 2024 to 2033.
Intragastric balloons are medical devices that do not require surgery and are created to aid in weight loss by taking up space in the stomach, leading to a sensation of fullness and decreased food consumption. These balloons are placed in the stomach through an endoscopic procedure and are filled with saline or gas to occupy a part of the stomach, reducing its capacity for food intake. This method helps people stick to low-calorie diets and develop healthier eating habits, which in turn supports weight loss. These balloons are especially advantageous for individuals dealing with obesity who may not be eligible for or prefer to avoid surgical procedures such as gastric bypass or sleeve gastrectomy.
The growth of the intragastric balloons market is driven by rise in the obesity rates related to various factors such as sedentary lifestyles, unhealthy dietary habits, and genetic predispositions. As these factors become more prevalent globally, the incidence of obesity continues to rise. Consequently, individuals are increasingly seeking effective weight loss solutions to mitigate these health risks and improve their overall well-being. This growing demand for obesity management solutions drives the market for interventions such as intragastric balloons, which offer a minimally invasive approach to weight loss. For instance, 57.0% of the patients who preferred minimally invasive treatment made their decision under the influence of the healthcare professionals as they recommended minimally invasive treatment and reported less perceived disadvantages following their treatment.
However, lack of reimbursement policies hinders the adoption of intragastric balloons. In many healthcare systems, the coverage for intragastric balloon procedures is expected to be insufficient or non-existent, resulting in high out-of-pocket costs for patients. This financial barrier deters individuals from seeking treatment, particularly those with limited financial resources or inadequate insurance coverage. On the other hand, introduction of new products offers lucrative opportunities for the growth of the market. For instance, in September 2022, Allurion Technologies, the U.S.-based medical device manufacturer, launched its weight loss solution, a swallowable gastric balloon, in India. The product claims to reduce weight by 10-15% on average within 16 weeks.
Segmentation Overview
The intragastric balloons industry is segmented into type, filling material, end user, and region. By type, the market is classified into single, dual, and triple. Depending on the filling material, it is bifurcated into gas filled and saline filled. According to end user, the market is categorized into hospitals, ambulatory surgical centers (ASC), and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the single segment generated the largest revenue in the intragastric balloons market in 2023.
Depending on the filling material, the saline filled segment held the highest share in the market in 2023.
According to end users, the hospitals segment accounted for the largest market share in 2023.
Region wise, North America dominated the intragastric balloons market in 2023.
Competitive Scenario
The major players operating in the intragastric balloons market include Obalon Therapeutics, Apollo Endosurgery Inc., Allurion Technologies Inc., Spatz Medical, ReShape Lifesciences, Lexel Medical, Endalis, MEDSIL, and Silimed. Other players in the intragastric balloons market include Districlass Medical, and Helioscopie. These players have adopted several strategies, including mergers & acquisitions, partnerships, collaborations, and product innovation & diversification to maintain their foothold in the market.
Intragastric balloons are medical devices that do not require surgery and are created to aid in weight loss by taking up space in the stomach, leading to a sensation of fullness and decreased food consumption. These balloons are placed in the stomach through an endoscopic procedure and are filled with saline or gas to occupy a part of the stomach, reducing its capacity for food intake. This method helps people stick to low-calorie diets and develop healthier eating habits, which in turn supports weight loss. These balloons are especially advantageous for individuals dealing with obesity who may not be eligible for or prefer to avoid surgical procedures such as gastric bypass or sleeve gastrectomy.
The growth of the intragastric balloons market is driven by rise in the obesity rates related to various factors such as sedentary lifestyles, unhealthy dietary habits, and genetic predispositions. As these factors become more prevalent globally, the incidence of obesity continues to rise. Consequently, individuals are increasingly seeking effective weight loss solutions to mitigate these health risks and improve their overall well-being. This growing demand for obesity management solutions drives the market for interventions such as intragastric balloons, which offer a minimally invasive approach to weight loss. For instance, 57.0% of the patients who preferred minimally invasive treatment made their decision under the influence of the healthcare professionals as they recommended minimally invasive treatment and reported less perceived disadvantages following their treatment.
However, lack of reimbursement policies hinders the adoption of intragastric balloons. In many healthcare systems, the coverage for intragastric balloon procedures is expected to be insufficient or non-existent, resulting in high out-of-pocket costs for patients. This financial barrier deters individuals from seeking treatment, particularly those with limited financial resources or inadequate insurance coverage. On the other hand, introduction of new products offers lucrative opportunities for the growth of the market. For instance, in September 2022, Allurion Technologies, the U.S.-based medical device manufacturer, launched its weight loss solution, a swallowable gastric balloon, in India. The product claims to reduce weight by 10-15% on average within 16 weeks.
Segmentation Overview
The intragastric balloons industry is segmented into type, filling material, end user, and region. By type, the market is classified into single, dual, and triple. Depending on the filling material, it is bifurcated into gas filled and saline filled. According to end user, the market is categorized into hospitals, ambulatory surgical centers (ASC), and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By type, the single segment generated the largest revenue in the intragastric balloons market in 2023.
Depending on the filling material, the saline filled segment held the highest share in the market in 2023.
According to end users, the hospitals segment accounted for the largest market share in 2023.
Region wise, North America dominated the intragastric balloons market in 2023.
Competitive Scenario
The major players operating in the intragastric balloons market include Obalon Therapeutics, Apollo Endosurgery Inc., Allurion Technologies Inc., Spatz Medical, ReShape Lifesciences, Lexel Medical, Endalis, MEDSIL, and Silimed. Other players in the intragastric balloons market include Districlass Medical, and Helioscopie. These players have adopted several strategies, including mergers & acquisitions, partnerships, collaborations, and product innovation & diversification to maintain their foothold in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
Key Market Segments
By Type
- Single
- Dual
- Triple
By Filling Material
- Gas Filled
- Saline Filled
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Obalon Therapeutics
- Apollo Endosurgery Inc.
- Allurion Technologies Inc.
- Spatz Medical
- ReShape Lifesciences
- Lexel Medical
- Endalis
- MEDSIL
- Silimed Indústria de Implantes Ltda.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: INTRAGASTRIC BALLOONS MARKET, BY TYPE
CHAPTER 5: INTRAGASTRIC BALLOONS MARKET, BY FILLING MATERIAL
CHAPTER 6: INTRAGASTRIC BALLOONS MARKET, BY END USER
CHAPTER 7: INTRAGASTRIC BALLOONS MARKET, BY REGION
CHAPTER 8: COMPETITIVE LANDSCAPE
CHAPTER 9: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
Key Market Players in the Intragastric Balloons Market include:- Obalon Therapeutics
- Apollo Endosurgery Inc.
- Allurion Technologies Inc.
- Spatz Medical
- ReShape Lifesciences
- Lexel Medical
- Endalis
- MEDSIL
- Silimed Indústria de Implantes Ltda.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 216 |
| Published | July 2024 |
| Forecast Period | 2023 - 2033 |
| Estimated Market Value ( USD | $ 32.2 million |
| Forecasted Market Value ( USD | $ 115.3 million |
| Compound Annual Growth Rate | 13.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
